Intellipharmaceutics International Company Profile (NASDAQ:IPCI)

About Intellipharmaceutics International

Intellipharmaceutics International logoIntellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. The Company's Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. It has developed several drug delivery systems and a pipeline of products and product candidates in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract, diabetes and pain. The Hypermatrix family of technologies includes IntelliFoam, IntelliGITransporter, IntelliMatrix, IntelliOsmotics, IntelliPaste, IntelliPellets, IntelliShuttle, Point of Divergence Drug Delivery System (nPODDDS) and Paradoxical OverDose Resistance Activating System (PODRAS). Its products include Focalin XR, Keppra XR, Effexor XR, Protonix, Seroquel XR, Lamictal XR, Pristiq, Oleptro, Coreg CR, OxyContin and Lyrica.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Delivery
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: IPCI
  • CUSIP:
Key Metrics:
  • Previous Close: $2.11
  • 50 Day Moving Average: $1.85
  • 200 Day Moving Average: $1.83
  • 52-Week Range: $28,747,000.00 - $1.41
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 5.28
  • P/E Growth: 0.00
  • Market Cap: $60.66M
  • Outstanding Shares: 28,747,000
  • Beta: 0.74
Profitability:
  • Net Margins: -325.20%
  • Return on Equity: -832.00%
  • Return on Assets: -189.42%
Debt:
  • Current Ratio: 0.25%
  • Quick Ratio: 0.25%
Additional Links:
Companies Related to Intellipharmaceutics International:

Analyst Ratings

Consensus Ratings for Intellipharmaceutics International (NASDAQ:IPCI) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $8.67 (310.74% upside)

Analysts' Ratings History for Intellipharmaceutics International (NASDAQ:IPCI)
Show:
DateFirmActionRatingPrice TargetDetails
7/22/2016Maxim GroupReiterated RatingBuyView Rating Details
7/5/2016Brean CapitalReiterated RatingBuy$8.00View Rating Details
10/13/2015MackieSet Price TargetBuy$12.00View Rating Details
2/24/2015NomuraDowngradeNeutralView Rating Details
(Data available from 9/25/2014 forward)

Earnings

Earnings History for Intellipharmaceutics International (NASDAQ:IPCI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/13/2016Q216($0.09)($0.08)$1.30 millionViewN/AView Earnings Details
10/9/2015Q315($0.04)($0.08)ViewN/AView Earnings Details
7/13/2015Q215($0.05)($0.06)$1.20 millionViewN/AView Earnings Details
4/14/2015($0.08)($0.04)ViewN/AView Earnings Details
2/23/2015($0.07)($0.06)ViewN/AView Earnings Details
10/15/2014Q3($0.05)($0.07)ViewN/AView Earnings Details
4/14/2014Q114$0.11$0.09$4.49 million$4.70 millionViewN/AView Earnings Details
2/18/2014($0.08)($0.31)ViewN/AView Earnings Details
4/3/2013Q113($0.12)($0.07)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Intellipharmaceutics International (NASDAQ:IPCI)
Current Year EPS Consensus Estimate: $-0.28 EPS
Next Year EPS Consensus Estimate: $0.40 EPS

Dividends

Dividend History for Intellipharmaceutics International (NASDAQ:IPCI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Intellipharmaceutics International (NASDAQ:IPCI)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Intellipharmaceutics International (NASDAQ:IPCI)
DateHeadline
streetinsider.com logoPre-Open Stock Movers 09/23: (MIFI) (BATS) (TWTR) Higher; (ENPH) (IPCI) (APRI) Lower (more...) (NASDAQ:IPCI)
www.streetinsider.com - September 24 at 10:08 AM
streetinsider.com logoAfter-Hours Stock Movers 09/22: (MIFI) (BATS) (IMPV) Higher; (ENPH) (IPCI) (AIR) Lower (more...) (NASDAQ:IPCI)
www.streetinsider.com - September 23 at 5:20 PM
rttnews.com logoARDM Awaits Data In Q4, FDA Clears TCMD Device, Newfound Interest For GLMD, GALT - RTT News (NASDAQ:IPCI)
www.rttnews.com - September 23 at 8:36 AM
streetinsider.com logoAfter-Hours Stock Movers 09/22: (MIFI) (BATS) (IMPV) Higher; (ENPH) (IPCI) (AIR) Lower (more...) - StreetInsider.com (NASDAQ:IPCI)
www.streetinsider.com - September 23 at 8:36 AM
smarteranalyst.com logoStock Update (NASDAQ:IPCI): Why IntelliPharmaCeutics Intl Inc (USA) Shares Jumped? Management Has No Clue - Smarter Analyst (NASDAQ:IPCI)
www.smarteranalyst.com - September 23 at 8:36 AM
News IconStocks in Mix Momentum- Pattern Energy Group (PEGI), IntelliPharmaCeutics International (IPCI), KeyCorp. (KEY) - Seneca Globe (NASDAQ:IPCI)
www.senecaglobe.com - September 23 at 8:36 AM
streetinsider.com logoIntellipharmaceutics (IPCI) Comments on Trading Activity; Says Not Aware of Any Corp. Developments - StreetInsider.com (NASDAQ:IPCI)
www.streetinsider.com - September 23 at 8:36 AM
News IconUnder the Microscope, Zeroing in at IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) - Duncan Research (NASDAQ:IPCI)
www.duncanindependent.com - September 23 at 8:36 AM
publicnow.com logoIntellipharmaceutics Responds to Recent Trading Activity (NASDAQ:IPCI)
www.publicnow.com - September 23 at 8:36 AM
News IconPenny Stock Investors Keen on Shares of IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) - Duncan Research (NASDAQ:IPCI)
www.duncanindependent.com - September 22 at 8:52 AM
News IconSell-side is Weighing in on Intellipharmaceutics International Inc. (NASDAQ:IPCI) Earnings & Targets - Frisco Fastball (NASDAQ:IPCI)
friscofastball.com - September 21 at 3:53 PM
News IconPenny Stock Investors Take an Interest in IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) - Duncan Research (NASDAQ:IPCI)
www.duncanindependent.com - September 21 at 3:53 PM
News IconKeen Investors Seek Information on IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) - Duncan Research (NASDAQ:IPCI)
www.duncanindependent.com - September 16 at 5:31 PM
News IconMover to Watch: Tessera Technologies, Inc. (NASDAQ:TSRA) , Intellipharmaceutics International Inc. (NASDAQ:IPCI) - Wall Street Times (press release) (NASDAQ:IPCI)
www.wallstreetnews24.com - September 15 at 6:04 PM
News IconStock Update, a Closer Look at IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) - Duncan Research (NASDAQ:IPCI)
www.duncanindependent.com - September 15 at 6:04 PM
News IconKeen Investors Narrowing Their Focus on IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) - Duncan Research (NASDAQ:IPCI)
www.duncanindependent.com - September 15 at 8:51 AM
News IconAnalysts Place Intellipharmaceutics International Inc. (NASDAQ:IPCI) Under the Lens of the Microscope - Post News (NASDAQ:IPCI)
www.kentuckypostnews.com - September 15 at 8:51 AM
News IconMover to Watch - Fiduciary/Claymore MLP Opportunity Fund (NYSE:FMO) , Intellipharmaceutics International Inc ... - Wall Street Times (press release) (NASDAQ:IPCI)
www.wallstreetnews24.com - September 14 at 5:46 PM
News IconWhat are Analysts Expecting for Intellipharmaceutics International Inc. (NASDAQ:IPCI) Earnings? - Frisco Fastball (NASDAQ:IPCI)
friscofastball.com - September 14 at 5:46 PM
News IconStock Showing Gains in Afternoon Trading: IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) - National Daily Press (NASDAQ:IPCI)
www.nationaldailypress.com - September 9 at 10:23 AM
News IconPlacing Intellipharmaceutics International Inc. (NASDAQ:IPCI) Shares Under the Microscope - Post News (NASDAQ:IPCI)
www.kentuckypostnews.com - September 8 at 5:33 PM
thestreet.com logo2 Big Companies and 1 Small One to Target in the Pharma/Biotech Space (NASDAQ:IPCI)
www.thestreet.com - September 8 at 9:34 AM
investornewswire.com logoCan Shares Of Intellipharmaceutics International Inc. (NASDAQ:IPCI) Get To $8? - Investor Newswire (NASDAQ:IPCI)
www.investornewswire.com - September 2 at 5:37 PM
News IconStock Gapping Up Pre-Market: IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) - Post News (NASDAQ:IPCI)
www.kentuckypostnews.com - September 1 at 5:34 PM
News IconStock in Review: Taking a Closer Look at Intellipharmaceutics International Inc. (NASDAQ:IPCI) Shares - Post News (NASDAQ:IPCI)
www.kentuckypostnews.com - September 1 at 8:39 AM
News IconIntellipharmaceutics International Inc. (NASDAQ:IPCI) Company In Focus: Analysts & Crowd Weigh in - Post News (NASDAQ:IPCI)
www.kentuckypostnews.com - August 25 at 5:43 PM
stockhouse.com logoIntellipharmaceutics International Inc T.I (NASDAQ:IPCI)
www.stockhouse.com - August 24 at 5:32 PM
News IconConsensus Weighing in on Intellipharmaceutics International Inc. (NASDAQ:IPCI) - Post News (NASDAQ:IPCI)
www.kentuckypostnews.com - August 19 at 5:40 PM
investornewswire.com logoWill Intellipharmaceutics International Inc. (NASDAQ:IPCI) Hit $8 Price Target? - Investor Newswire (NASDAQ:IPCI)
www.investornewswire.com - August 19 at 5:40 PM
News IconAdaptive Ad Systems, Inc. (OTC Pink: AATV), 400% Growth Over 2016 Projected $9 Million Revenue, $3.2 Million Net Profit (NASDAQ:IPCI)
ih.advfn.com - August 18 at 8:42 AM
investornewswire.com logoCan Shares Of Intellipharmaceutics International Inc. (NASDAQ:IPCI) Hit $8? - Investor Newswire (NASDAQ:IPCI)
www.investornewswire.com - July 30 at 8:35 AM
investornewswire.com logoIs $8 Price Target Attainable For Intellipharmaceutics International Inc. (NASDAQ:IPCI)? - Investor Newswire (NASDAQ:IPCI)
www.investornewswire.com - July 22 at 5:35 PM
News IconEarnings Focus and Crowd Sourced Sentiment Review for Intellipharmaceutics International Inc. (NASDAQ:IPCI) - TGP (NASDAQ:IPCI)
telanaganapress.com - July 21 at 5:50 PM
News IconIntellipharmaceutics International Inc. (NASDAQ:IPCI): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:IPCI)
www.engelwooddaily.com - July 20 at 8:43 AM
News IconTrading Performance and Target Watch for Intellipharmaceutics International Inc. (NASDAQ:IPCI) - Press Telegraph (NASDAQ:IPCI)
presstelegraph.com - July 18 at 10:54 AM
investornewswire.com logoStrong Sell Calls For Intellipharmaceutics International Inc. (NASDAQ:IPCI) At 0 - Investor Newswire (NASDAQ:IPCI)
www.investornewswire.com - July 16 at 9:02 AM
News IconIntellipharmaceutics International Inc. (NASDAQ:IPCI) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:IPCI)
www.engelwooddaily.com - July 13 at 8:34 AM
News IconAnalyst Target and Average Rating Watch: Intellipharmaceutics International Inc. (NASDAQ:IPCI) - Press Telegraph (NASDAQ:IPCI)
presstelegraph.com - July 13 at 8:34 AM
investornewswire.com logoIs $12 Within Reach For Intellipharmaceutics International Inc. (NASDAQ:IPCI)? - Investor Newswire (NASDAQ:IPCI)
www.investornewswire.com - July 10 at 10:00 AM
fiscalstandard.com logoBroker Outlook For Intellipharmaceutics International Inc. (IPCI) - Fiscal Standard (NASDAQ:IPCI)
www.fiscalstandard.com - July 8 at 8:33 AM
ftsenews.co.uk logoNew Broker Ratings For Intellipharmaceutics International Inc. (IPCI) - FTSE News (NASDAQ:IPCI)
www.ftsenews.co.uk - July 6 at 5:53 PM
investornewswire.com logoIntellipharmaceutics International Inc. (NASDAQ:IPCI) Expected to Reach Highs Of $12 - Investor Newswire (NASDAQ:IPCI)
www.investornewswire.com - July 3 at 10:03 AM
ftsenews.co.uk logoIntellipharmaceutics International Inc. (IPCI) Updated Price Targets - FTSE News (NASDAQ:IPCI)
www.ftsenews.co.uk - June 29 at 5:36 PM
investornewswire.com logoEarnings Surprise in Focus: Intellipharmaceutics International Inc. (NASDAQ:IPCI) - Investor Newswire (NASDAQ:IPCI)
www.investornewswire.com - June 29 at 5:36 PM
kcregister.com logoInvestors Alert: IntelliPharmaCeutics International Inc. (NASDAQ:IPCI), PrivateBancorp, Inc. (NASDAQ:PVTB), Bristol ... - KC Register (NASDAQ:IPCI)
www.kcregister.com - June 29 at 8:30 AM
fiscalstandard.com logoNext Weeks Broker Price Targets For Intellipharmaceutics International Inc. (IPCI) - Fiscal Standard (NASDAQ:IPCI)
www.fiscalstandard.com - June 27 at 10:00 AM
investornewswire.com logoStrong Sell Calls Recommendations For Intellipharmaceutics International Inc. (NASDAQ:IPCI) At 0 - Investor Newswire (NASDAQ:IPCI)
www.investornewswire.com - June 26 at 5:03 PM
investornewswire.com logoCan Intellipharmaceutics International Inc. (NASDAQ:IPCI) Surprise Analysts this Quarter? - Investor Newswire (NASDAQ:IPCI)
www.investornewswire.com - June 19 at 9:50 AM
investornewswire.com logoStrong Buy Calls Count For Intellipharmaceutics International Inc. (NASDAQ:IPCI) At 2 - Investor Newswire (NASDAQ:IPCI)
www.investornewswire.com - June 19 at 9:50 AM
finance.yahoo.com logoIntellipharmaceutics Closes Public Offering for US$5.2 Million (NASDAQ:IPCI)
finance.yahoo.com - June 6 at 5:30 PM

Social

Intellipharmaceutics International (NASDAQ:IPCI) Chart for Sunday, September, 25, 2016


Last Updated on 9/25/2016 by MarketBeat.com Staff